loader

Fortrea, a leading global contract research organization (CRO), has launched its AI Innovation Studio, marking a significant investment in the future of clinical trials (link).

What is the AI Innovation Studio?

The studio aims to develop and deploy AI and machine learning (ML) technologies to enhance speed, agility, quality, and patient safety in clinical research. This initiative empowers people to focus on the critical human elements of clinical trials.

“Patients around the world are waiting for novel, life-changing treatments. With AI, we now have the power—and the obligation—to help deliver solutions to them faster,” said Fortrea’s Chief Information Officer Alejandro Martinez Galindo.

Key Objectives

  • Partner with customers to provide bespoke technology solutions.
  • Develop new technology innovations to improve clinical trial delivery.
  • Support existing infrastructure with enhanced technology for better user experiences.

Technologies Under Development

The studio is working on various technologies, including:

  • Smartphone-enabled data collection
  • Specialized large language models
  • Symbolic AI with real-valued logic
  • Mixed reality and augmented intelligence
  • Advanced data mining and predictive analytics
  • Digital twinning

Impact on Clinical Trials

The strategic application of these technologies is expected to improve patient recruitment and retention, protocol optimization, quality monitoring, and overall delivery speed and quality. These advancements will also enhance the patient experience and productivity for Fortrea’s customers and employees.

Future Vision

Fortrea is focused on a future vision of the CRO industry, building towards the future rather than from the past. Brian Dolan, Vice President of Artificial Intelligence & Machine Learning, emphasized the responsible and ethical development of AI, prioritizing patient safety and privacy.

About Fortrea

Fortrea is a global provider of clinical development solutions to the life sciences industry. They partner with biopharmaceutical, biotechnology, medical device, and diagnostic companies to drive healthcare innovation. Fortrea offers phase I-IV clinical trial management, clinical pharmacology, and consulting services, leveraging three decades of experience across more than 20 therapeutic areas. Learn more at Fortrea.com and follow them on LinkedIn and X (formerly Twitter).



Leave a Reply

Your email address will not be published. Required fields are marked *